Can shorter radiation schedules spare breast skin?

NCT ID NCT05775757

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This study follows breast cancer patients who have had curative surgery and are receiving hypofractionated radiation therapy—shorter treatment courses lasting one to three weeks. Researchers will track changes in breast skin, fibrosis, cosmetic appearance, and patient-reported outcomes using photos, a fibrometer, and questionnaires. The goal is to understand which factors influence skin toxicity and cosmetic results, helping to refine radiation approaches for better quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Hypofractionated radiation therapy
What this could lead to
Could help tailor radiation dosing to minimize skin damage and improve cosmetic outcomes for breast cancer patients.
What could go wrong
As an observational study, it cannot prove cause and effect. Results depend on patient-reported and physician-assessed measures, which may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Samsung Medical Center

    Seoul, Seoul, 06351, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.